Overview

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is compare overall survival of the test arm (CPT-11/S-1 combination) to the control arm (CPT-11 alone) in the subjects with S-1 refractory advanced gastric cancer.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Japan Clinical Cancer Research Organization
Collaborator:
Taiho Pharmaceutical Co., Ltd.
Treatments:
Camptothecin
Irinotecan